Tissue chips - innovative tools for drug development and disease modeling.

The high rate of failure during drug development is well-known, however recent advances in tissue engineering and microfabrication have contributed to the development of microphysiological systems (MPS), or 'organs-on-chips' that recapitulate the function of human organs. These 'tissue chips' could be utilized for drug screening and safety testing to potentially transform the early stages of the drug development process. They can also be used to model disease states, providing new tools for the understanding of disease mechanisms and pathologies, and assessing effectiveness of new therapies. In the future, they could be used to test new treatments and therapeutics in populations - via clinical trials-on-chips - and individuals, paving the way for precision medicine. Here we will discuss the wide-ranging and promising future of tissue chips, as well as challenges facing their development.

[1]  K. Parker,et al.  Acute pergolide exposure stiffens engineered valve interstitial cell tissues and reduces contractility in vitro. , 2016, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[2]  D. L. Taylor,et al.  Fluorescent protein biosensors applied to microphysiological systems , 2015, Experimental biology and medicine.

[3]  N. Elvassore,et al.  Microfluidic technology enhances the potential of human pluripotent stem cells. , 2016, Biochemical and biophysical research communications.

[4]  L. Mccawley,et al.  Variation in diffusion of gases through PDMS due to plasma surface treatment and storage conditions , 2014, Biomedical microdevices.

[5]  L. Smirnova,et al.  A Human Brain Microphysiological System Derived from Induced Pluripotent Stem Cells to Study Neurological Diseases and Toxicity , 2016, ALTEX.

[6]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[7]  W. Pardridge.  The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.

[8]  Carole Federico,et al.  Consider drug efficacy before first-in-human trials , 2017, Nature.

[9]  M. Bissell,et al.  Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. , 2006, Annual review of cell and developmental biology.

[10]  Yuejun Kang,et al.  Surface chemical modification of poly(dimethylsiloxane) for the enhanced adhesion and proliferation of mesenchymal stem cells. , 2013, ACS applied materials & interfaces.

[11]  Yuejun Kang,et al.  Simple surface engineering of polydimethylsiloxane with polydopamine for stabilized mesenchymal stem cell adhesion and multipotency , 2015, Scientific Reports.

[12]  Rahul C. Deo,et al.  Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease. , 2017, Cell stem cell.

[13]  Kristin M. Fabre,et al.  Organs-on-chips (microphysiological systems): tools to expedite efficacy and toxicity testing in human tissue , 2014, Experimental biology and medicine.

[14]  Gang Wang,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014 .

[15]  Albert Gough,et al.  Corrigendum: Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle , 2017, Scientific Reports.

[16]  D. Schaffer,et al.  Biophysical regulation of epigenetic state and cell reprogramming. , 2013, Nature materials.

[17]  Marc Bickle,et al.  Screening out irrelevant cell-based models of disease , 2016, Nature Reviews Drug Discovery.

[18]  D. Beebe,et al.  PDMS absorption of small molecules and consequences in microfluidic applications. , 2006, Lab on a chip.

[19]  Michael Schumacher,et al.  Modeling human development and disease in pluripotent stem cell-derived gastric organoids , 2014, Nature.

[20]  N. Benvenisty,et al.  Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. , 2011, Cell stem cell.

[21]  Peter Molnar,et al.  Microphysiological systems and low-cost microfluidic platform with analytics , 2013, Stem Cell Research & Therapy.

[22]  L Findlay,et al.  Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T‐cells , 2010, British journal of pharmacology.

[23]  Lucas H. Hofmeister,et al.  Scaling and systems biology for integrating multiple organs-on-a-chip. , 2013, Lab on a chip.

[24]  Luke P. Lee,et al.  Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications , 2015, Scientific Reports.

[25]  Lucie A Low,et al.  Tissue chips to aid drug development and modeling for rare diseases , 2016, Expert opinion on orphan drugs.

[26]  Daniel C Leslie,et al.  A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice , 2012, Science Translational Medicine.

[27]  Megan L. McCain,et al.  Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. , 2011, Lab on a chip.

[28]  S. George,et al.  Design considerations to minimize the impact of drug absorption in polymer-based organ-on-a-chip platforms. , 2017, Lab on a chip.

[29]  N. Jeon,et al.  Microfluidic culture platform for neuroscience research , 2006, Nature Protocols.

[30]  J. Rocheleau,et al.  A microfluidic device designed to induce media flow throughout pancreatic islets while limiting shear-induced damage. , 2013, Lab on a chip.

[31]  Andrew P. Feinberg,et al.  Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.

[32]  S. Sia,et al.  Human Skin Constructs with Spatially Controlled Vasculature Using Primary and iPSC‐Derived Endothelial Cells , 2016, Advanced healthcare materials.

[33]  Alan Wells,et al.  A microphysiological system model of therapy for liver micrometastases , 2014, Experimental biology and medicine.

[34]  Josue A. Goss,et al.  Microfluidic heart on a chip for higher throughput pharmacological studies. , 2013, Lab on a chip.

[35]  Dermot Kelleher,et al.  The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research. , 2016, The Lancet. Haematology.

[36]  F. Sonntag,et al.  A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. , 2013, Lab on a chip.

[37]  D. Ingber,et al.  Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. , 2012, Lab on a chip.

[38]  D. Ingber,et al.  From 3D cell culture to organs-on-chips. , 2011, Trends in cell biology.

[39]  Shuichi Takayama,et al.  Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems , 2007, Proceedings of the National Academy of Sciences.

[40]  Stem cell reprogramming: A 3D boost. , 2016, Nature materials.

[41]  Donald E Ingber,et al.  Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[42]  Asher Mullard.  Stem-cell discovery platforms yield first clinical candidates , 2015, Nature Reviews Drug Discovery.

[43]  F. Sonntag,et al.  A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. , 2015, Lab on a chip.

[44]  Shuichi Takayama,et al.  Organ-on-a-chip and the kidney , 2015, Kidney research and clinical practice.

[45]  Mikael Benson,et al.  Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems , 2015, Genome Biology.

[46]  Hanry Yu,et al.  Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. , 2009, Lab on a chip.

[47]  Todd Thorsen,et al.  High-density microfluidic arrays for cell cytotoxicity analysis. , 2007, Lab on a chip.

[48]  Danny D Shen,et al.  Development of a microphysiological model of human kidney proximal tubule function. , 2016, Kidney international.

[49]  Yuejun Kang,et al.  The effects of poly(dimethylsiloxane) surface silanization on the mesenchymal stem cell fate. , 2015, Biomaterials science.

[50]  Tza-Huei Wang,et al.  Integration and application of vitrified collagen in multilayered microfluidic devices for corneal microtissue culture. , 2009, Lab on a chip.

[51]  Yordan Kostov,et al.  The Design and Fabrication of Three‐Chamber Microscale Cell Culture Analog Devices with Integrated Dissolved Oxygen Sensors , 2008, Biotechnology progress.

[52]  L. Griffith,et al.  Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system , 2014, British Journal of Cancer.

[53]  Barry S. Coller,et al.  Traversing the Valley of Death: A Guide to Assessing Prospects for Translational Success , 2009, Science Translational Medicine.

[54]  J. Arrowsmith.  Trial watch: Phase II failures: 2008–2010 , 2011, Nature Reviews Drug Discovery.

[55]  C. David Page,et al.  Human pluripotent stem cell-derived neural constructs for predicting neural toxicity , 2015, Proceedings of the National Academy of Sciences.

[56]  Qing Yang,et al.  Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor. , 2015, Biomicrofluidics.

[57]  Matthew H. M. Lim,et al.  Perfused multiwell plate for 3D liver tissue engineering. , 2010, Lab on a chip.

[58]  David V. Schaffer,et al.  A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation , 2013, Proceedings of the National Academy of Sciences.

[59]  Albert Gough,et al.  A human liver microphysiology platform for investigating physiology, drug safety, and disease models , 2016, Experimental biology and medicine.

[60]  J. Collins,et al.  Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip , 2015, Proceedings of the National Academy of Sciences.

[61]  D. Ingber,et al.  Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[62]  Olga Kovbasnjuk,et al.  Human Enteroids as a Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology. , 2016, Gastroenterology.

[63]  Albert van den Berg,et al.  Microfluidic organ-on-chip technology for blood-brain barrier research , 2016, Tissue barriers.

[64]  William McLamb,et al.  Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs , 2016, Scientific Reports.

[65]  Stephanie J Hachey,et al.  3D microtumors in vitro supported by perfused vascular networks , 2016, Scientific Reports.

[66]  Gordana Vunjak-Novakovic,et al.  Engineering bone tissue substitutes from human induced pluripotent stem cells , 2013, Proceedings of the National Academy of Sciences.

[67]  Steven C George,et al.  A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications. , 2017, Lab on a chip.

[68]  Madeline A. Lancaster,et al.  Cerebral organoids model human brain development and microcephaly , 2013, Nature.

[69]  Nam-Trung Nguyen,et al.  Oxygen plasma treatment for reducing hydrophobicity of a sealed polydimethylsiloxane microchannel. , 2010, Biomicrofluidics.

[70]  L. O’Driscoll,et al.  Three-dimensional cell culture: the missing link in drug discovery. , 2013, Drug discovery today.

[71]  J. Kim,et al.  Microphysiological modeling of the reproductive tract: A fertile endeavor , 2014, Experimental biology and medicine.

[72]  Kevin E. Healy,et al.  μOrgano: A Lego®-Like Plug & Play System for Modular Multi-Organ-Chips , 2015, PloS one.

[73]  M. Pangalos,et al.  Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework , 2014, Nature Reviews Drug Discovery.

[74]  James C. Weaver,et al.  Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro , 2017, PloS one.

[75]  Min Jun Kim,et al.  Microfluidics-generated pancreatic islet microfibers for enhanced immunoprotection. , 2013, Biomaterials.

[76]  Shuichi Takayama,et al.  Quantitative Analysis of Molecular Absorption into PDMS Microfluidic Channels , 2012, Annals of Biomedical Engineering.

[77]  W M Reichert,et al.  Human Vascular Microphysiological System for in vitro Drug Screening , 2016, Scientific Reports.

[78]  Arti Ahluwalia,et al.  Glucose and Fatty Acid Metabolism in a 3 Tissue In-Vitro Model Challenged with Normo- and Hyperglycaemia , 2012, PloS one.

[79]  Lauran R. Madden,et al.  Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs , 2015, eLife.

[80]  Deyu Li,et al.  Metabolic consequences of interleukin-6 challenge in developing neurons and astroglia , 2014, Journal of Neuroinflammation.

[81]  Adrian Ranga,et al.  Defined three-dimensional microenvironments boost induction of pluripotency. , 2016, Nature materials.

[82]  Kristin M. Fabre,et al.  The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline , 2013, Stem Cell Research & Therapy.

[83]  J. Wells,et al.  Generating human intestinal tissue from pluripotent stem cells in vitro , 2011, Nature Protocols.

[84]  Orlando S. Hoilett,et al.  Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit , 2016, Journal of Neuroinflammation.

[85]  P. Hewitt,et al.  Biomarkers for Drug-Induced Renal Damage and Nephrotoxicity—An Overview for Applied Toxicology , 2011, The AAPS Journal.

[86]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[87]  T. Hope,et al.  A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle , 2017, Nature Communications.

[88]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[89]  Uwe Marx,et al.  Chip-based liver equivalents for toxicity testing--organotypicalness versus cost-efficient high throughput. , 2013, Lab on a chip.

[90]  Donald E Ingber,et al.  Microfabrication of human organs-on-chips , 2013, Nature Protocols.

[91]  Linda G. Griffith,et al.  Human Vascular Tissue Models Formed from Human Induced Pluripotent Stem Cell Derived Endothelial Cells , 2014, Stem Cell Reviews and Reports.

[92]  J. Kim,et al.  Human fallopian tube epithelium co-culture with murine ovarian follicles reveals crosstalk in the reproductive cycle. , 2016, Molecular human reproduction.

[93]  J. Arrowsmith.  Trial watch: Phase III and submission failures: 2007–2010 , 2011, Nature Reviews Drug Discovery.

[94]  Alan Wells,et al.  Liver metastases: Microenvironments and ex-vivo models , 2016, Experimental biology and medicine.

[95]  Alireza Mashaghi,et al.  An end-user perspective on Organ-on-a-Chip : Assays and usability aspects , 2017 .

[96]  Gordana Vunjak-Novakovic,et al.  Tissue-engineered models of human tumors for cancer research , 2015, Expert opinion on drug discovery.